Apoptosis in patients with myelodysplastic syndromes: Differential involvement of marrow cells in 'good' versus 'poor' prognosis patients and correlation with apoptosis-related genes

Leukemia

Volumn 13, Issue 10, 1999, Pages 1554-1563

  Tsoplou, P ^a   Kouraklis Symeonidis, A ^a   Thanopoulou, E ^a   Zikos, P ^a   Orphanos, V ^a   Zoumbos, N C ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Apoptosis; Myelodysplastic syndrome

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOPENIA; EXTRACTION; FEMALE; GEL ELECTROPHORESIS; GENE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032848438     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401538     Document Type: Article

References (30)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. FAB Co-operative Group: proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
2. Greenberg PL, Mara B. The preleukemic syndrome. Correlation of in vitro parameters of granulopoiesis with clinical features. Am J Med 1979; 66: 951-954.
3. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
4. Yuan J, Angelucci E, Lucarelli G, Aljurf M, Snyder LM, Kieler CR, Ma L, Schrier SL. Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe β-thalassemia (Cooley's anemia). Blood 1993; 82: 374-377.
5. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Loew J, Marcus B, Khan Z, Chaney C, Showel J, Gregory S, Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268-276.
6. Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, Alvi S, Shetty V, Dameron S, Wright V, Adler S, Loew J, Shott S, Ali SN, Preisler H. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastic reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 1995; 48: 143-154.
7. Lepelley P, Campergue L, Grardel N, Preudhomme C, Cosson A, Fenaux P. Is apoptosis a massive process in myelodysplastic syndromes? Br J Haematol 1996; 95: 368-371.
8. Rajapaksa R, Ginzton N, Rott LS, Greenberg PL. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 1996; 88: 4275-4287.
9. Yonish-Rouach E, Resnitsky D, Lotem J, Sachs K, Kim-Chi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-347.
10. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in IL-3 dependent cell line suppresses cell cycle arrest and accelerated apoptosis. Oncogene 1991; 6: 1915-1922.
11. Iton N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
12. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
13. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre B cells. Nature 1988; 335: 440-442.
14. Sellins KS, Cohen JJ. Gene inducation by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987; 139: 3199-3206.
15. Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D. Bone marrow-derived stromal cells prevent apoptotic cells death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 2370-2377.
16. Ling YH, Priebe W, Perez-Soler R. Apoptosis induced by anthracyclin antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 1993; 53: 1845-1852.
17. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162: 156-159.
18. Miltenyi S, Muller W, Weicher W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990; 11: 231-238.
19. Gavrieli V, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
20. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993; 53: 1945-1951.
21. Sinha BK, Yamazaki H, Eliot HM, Schneider E, Borner MM, O'Connor PM. Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumour cells. Biochem Biophys Acta 1995; 1270: 12-18.
22. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
23. Cox DR. Regression models and life tables. JR Stat Soc (B) 1972; 34: 187-202.
24. Cortelezzi A, Stefano MD, Sarina B, Glannini S, Pomati M, Silvestris I, Cattaneo C, Lambertenghi D, Cristiani S, Majolo AT. Apoptosis in myelodysplastic syndromes (MDS): putative role of the bcl-2 proto-oncogene. Blood 1996; 88 (Suppl. 1): 95a.
25. + cells associated with oxidative stress in patients with myelodysplastic syndromes. Blood 1996; 88 (Suppl. 1): 95a.
26. Alvi S, Borok R, Mundle S, Gao XZ, Shetty V, Hines C, Robin E, Rifkin S, Klein M, Alston D, Hernandez B, Hsu WT, Gezer S, Gregory S, Raza A. Detection of high molecular weight DNA as evidence of apoptosis in myelodysplasia. Blood 1995; 86 (Suppl. 1): 334a.
27. Silva A, Wyllie A, Collins MKL. p53 is not required for regulation of apoptosis or radioprotection by interleukin-3. Blood 1997; 89: 2717-2722.
28. Vaux DL, Weissman IL. Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2. Mol Cel Biol 1993; 13: 7000-7005.
29. Geissler K, Hinterberger W, Jager U, Bettelheim P, Neumann E, Haas O, Ambros P, Chott A, Radaszkiewicz T, Lechner K. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes. Blut 1988; 57: 45-51.
30. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP, Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091-3096.